Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.31.555778Source: DataRank Database

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Sonya M. Mumper ORCID,Hazel Q. Shanks,Kathleen A. Yates ORCID,Jonathan B. Mandell ORCID,Michael E. Zegans ORCID

Live enrichment

PubMed:37693441 OpenAlex:https://openalex.org/W4386349620

NEI NIH HHS

Grant: P30 EY008098

NEI NIH HHS

Grant: R01 EY027331

greenLicense: cc-by

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/08/31/2023.08.31.555778.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.08.31.555778

repositoryhttp://dx.doi.org/10.1101/2023.08.31.555778

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37693441

Fields of Study

Ocular Infections and TreatmentsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and Efficacy

Keywords

TobramycinPseudomonas aeruginosaKeratitisMicrobiologyCiprofloxacinCorneaMinimum inhibitory concentrationAntibioticsLevofloxacinAntimicrobialCephalosporinBiologyMedicinePharmacologyBacteriaGentamicinOphthalmologyantibiotic resistancecefiderocolocular infection

Sustainable Development Goals

SDG 0: Good health and well-being